siRNA treatment lowers triglycerides in clients with rare problem

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride degrees through 80% and decreased the risk of pancreatitis in clients along with chronic chylomicronemia, with or without a hereditary diagnosis.